This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Regents of the University of Minnesota. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Innovations and Contributions of Aaron Lyman Sarver
Introduction
Aaron Lyman Sarver is an accomplished inventor based in Saint Paul, MN (US). He has made significant contributions to the field of medical diagnostics and therapeutics, holding a total of 2 patents. His work focuses on the utilization of endogenous retrovirus proteins and lymphoma prognostic methods.
Latest Patents
One of Sarver's latest patents is titled "Compositions and methods involving endogenous retrovirus proteins." This disclosure describes methods and compositions that involve endogenous retrovirus proteins as diagnostic markers and/or therapeutic agents. The detection of endogenous retrovirus envelope proteins on a cell surface can indicate early neoplasticity of the cell. Antibody compositions that specifically bind to cell-surface-expressed endogenous retrovirus proteins may be used in such diagnostic methods. Overexpression of the endogenous retrovirus proteins can slow cell growth and decrease cell viability. Another significant patent is "Lymphoma prognostic methods and kits." This method involves analyzing a tumor tissue sample from a subject for expression of CD28, ABCA5, CCDC3, and SMOC2. The CD28:ABCA5 expression ratio differentiates T-cell tumors from B-cell tumors, while the CCDC3:SMOC2 expression ratio differentiates different T-cell tumors. The method can further include administering to the subject an appropriate treatment for the form of lymphoma identified by performing the method.
Career Highlights
Aaron Lyman Sarver is affiliated with the Regents of the University of Minnesota, where he continues to advance his research and innovations. His work has the potential to significantly impact the field of oncology and improve diagnostic methods for lymphoma.
Collaborations
Some of his notable coworkers include Robyn Lynn Leary and Anindya Bagchi, who contribute to the collaborative research environment at the university.
Conclusion
Aaron Lyman Sarver's innovative work in the field of medical diagnostics showcases his dedication to advancing healthcare solutions. His patents reflect a commitment to improving diagnostic methods and therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile